|
|
Current Active NH/VT LCD |
L553 - Botulinum Toxin Type A L564 - Flow Cytometry L601 - Debridement of the Toenails L663 - Cardiovascular Imaging Studies * L669 - Holter Monitors - Long Term ECG/EKG Monitoring L4333 - Diagnostic Mammography * L4336 - Audiology Services * L4339 - Outpatient Physical Therapy* L4340 - Chronic Pulmonary Disease Treatment Services * L4342 - Removal of Skin Lesions * L12391 - Partial Hospitalization Program * L20387 - Stretta Procedure * L20980 - Skilled Nursing Facilities * L25211 - Erythropoietin Stimulating Agents (ESA) * L25275 - Category III CPT Codes * L25507 - Psychiatric Inpatient Hospitalization * L25650 - Homocycteine Level Serum L25714 - Inpatient Rehabilitation Facility * L25820 - Drugs and Biologicals, Coverage of, for Label and Off-Label Uses * L25879 - Acid Phosphatase L26003 - Biologic Proatducts for Wound Tratment and Surgical Interventions * L26375 - B-type Natriuretic Peptide (BNP) Testing L26404 - Colonoscopy/Sigmoidoscopy/Proctosigmoidoscopy L26409 - Dynamic Electrocardiography (EKG, ECG) L26439 - Vertebroplasty and Kyphoplasty (Percutaneous) L26448 - Blepharoplasty L26865 - Apheresis * = Not-All-Inclusive Policies |
190.12 Culture, Bacterial, Urine 190.13 Human Immunodeficiency Virus Testing (Prognosis including Monitoring) 190.14 Human Immunodeficiency Virus Testing (Diagnosis) 190.15 Blood Counts 190.16 Partial Thromboplastin Time 190.17 Prothrombin Time 190.18 Serum Iron Studies 190.19 Collagen Crosslinks, Any Method 190.20 Blood Glucose Testing 190.21 Glycated Hemoglobin / Glycated Protein 190.22 Thyroid Testing 190.23 Lipids 190.24 Digoxin Therapeutic Drug Assay 190.25 Alpha-fetoprotein 190.26 Carcinoembryonic Antigen 190.27 Human Chorionic Gonadotropin 190.28 Tumor Antigen by Immunoassay -CA125 190.29Tumor Antigen by Immunoassay CA15-3/CA27.29 190.30 Tumor Antigen by Immunoassay CA19-9 190.31 Prostate Specific Antigen 190.32 Gamma Glutamyl Transferase 190.33 Hepatitis Panel 190.34 Fecal Occult Blood |
Medicare National Coverage Decisions (NCD) |